Application

19506637 · 3-(4-CYCLO-PROPOXYBENZYL)-1-(2,4-DIFLUOROBENZYL)-1 -(1-METHYLPIPERIDIN-4-YL)UREA FOR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH THE SEROTONIN-RECEPTOR 5-HT

Filed 2026-01-29 · Pending The official file ↗ · Art unit · ACADIA PHARMACEUTICALS INC. · MICHAEL BEST & FRIEDRICH LLP (Mke)

Office actions

first was

RCEs

no appeal

To first action

n/a

to disposition n/a

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.